Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00878215 · ClinicalTrials.gov registry record · Phase 2

Clinical Application of Image-Guided Liver Surgery

A Phase 2 study, sponsored by Washington University School of Medicine.

Terminated
Registry status
Phase 2
Development phase
40
Enrollment target

NCT00878215: Clinical Trial Phase 2 study, sponsored by Washington University School of Medicine.

NCT00878215 is a Phase 2 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 40 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00878215, a Phase 2 study, was terminated before completion, sponsored by Washington University School of Medicine.

TERMINATED
Registry status
Phase 2
Development phase
40 participants
Enrollment target

Study Summary

Image-guided surgery is a new technology, which is used to create 3-D pictures that generate a map of the liver. This map will allow surgeons to know the exact anatomical location of their instruments, including instances when direct visualization is not possible. This study is designed to determine the safety and feasibility of using image-guided techniques for treatment of liver tumors. The overall goal of this study is to use image-guided surgery for the improvement of the surgeon's ability to remove liver tumors.

Primary Outcome

* 10 successful intraoperative registrations with no more than 30% failure rate over all the cases will be considered a successful endpoint * A successful registration is defined as one which yields an RMS surface residual of ≤ 10 mm and is determined to be success after qualitative evaluation.

Interventions

  • DEVICE Explorer Liver Image Guided System
  • DEVICE Explorer Liver Passive Tracking
  • PROCEDURE Liver surgery
  • PROCEDURE Liver abalation

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2002-10-24
Est. Completion 2011-05-25
Phase Phase 2

Why NCT00878215 stopped before completion

NCT00878215 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower).

The record links to 0 conditions, and to 4 interventions - of which Explorer Liver Image Guided System is the first listed.

NCT00878215 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00878215 about?

NCT00878215 is a clinical study titled "Clinical Application of Image-Guided Liver Surgery". Image-guided surgery is a new technology, which is used to create 3-D pictures that generate a map of the liver. This map will allow surgeons to know the exact anatomical location of their instruments, including instances when direct visualization is not possible. This study is designed to determine...

What is the current status of trial NCT00878215?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2002-10-24. Estimated completion is 2011-05-25.

What interventions are being tested in trial NCT00878215?

The interventions under investigation include: Explorer Liver Image Guided System (DEVICE), Explorer Liver Passive Tracking (DEVICE), Liver surgery (PROCEDURE), Liver abalation (PROCEDURE).

Who is sponsoring clinical trial NCT00878215?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00878215's enrollment target sits among peer trials

40 1362nd of 2000 higher than 542 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00878215, the US trial registry maintained by the National Library of Medicine. NCT00878215 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.